MicroRNA-33b inhibits breast cancer metastasis by targeting HMGA2, SALL4 and Twist1

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Lin, Yancheng ^a   Liu, Allan Yi ^a   Fan, Chuannan ^a   Zheng, Hong ^a   Li, Yuan ^a   Zhang, Chuankai ^b   Wu, Shasha ^a   Yu, Donghong ^a   Huang, Zhengjie ^b   Liu, Fan ^a   Luo, Qi ^b   Yang, Chaoyong James ^a   Ouyang, Gaoliang ^a  

^a XIAMEN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN; MICRORNA; MIRN33 MICRORNA, HUMAN; NUCLEAR PROTEIN; PROTEIN BINDING; SALL4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TWIST RELATED PROTEIN 1; TWIST1 PROTEIN, HUMAN;

BREAST TUMOR; CANCER STEM CELL; FEMALE; GENETICS; HUMAN; MCF-7 CELL LINE; METABOLISM; PATHOLOGY; SECONDARY;

BREAST NEOPLASMS; FEMALE; HMGA2 PROTEIN; HUMANS; MCF-7 CELLS; MICRORNAS; NEOPLASTIC STEM CELLS; NUCLEAR PROTEINS; PROTEIN BINDING; TRANSCRIPTION FACTORS; TWIST-RELATED PROTEIN 1;

EID: 84929104788     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09995     Document Type: Article

References (49)

1. DeSantis, C.,Ma, J., Bryan, L. & Jemal, A. Breast cancer statistics, 2013. CA Cancer J. Clin. 64, 52-62 (2014).
2. Hong, W. & Dong, E. The past, present and future of breast cancer research in China. Cancer Lett. 351, 1-5 (2014).
3. Ravdin, P. M. et al. The decrease in breast-cancer incidence in 2003 in the United States. N. Engl. J. Med. 356, 1670-1674 (2007).
4. Visvader, J. E.& Lindeman, G. J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8, 755-768 (2008).
5. Wang, Z. & Ouyang, G. Periostin: a bridge between cancer stem cells and their metastatic niche. Cell Stem Cell 10, 111-112 (2012).
6. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J. & Clarke, M. F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983-3988 (2003).
7. Ricci-Vitiani, L. et al. Identification and expansion of human colon-cancer-initiating cells. Nature 445, 111-115 (2007).
8. Singh, S. K. et al. Identification of human brain tumour initiating cells. Nature 432, 396-401 (2004).
9. Schatton, T. et al. Identification of cells initiating humanmelanomas. Nature 451, 345-349 (2008).
10. Gupta, P. B. et al. Cancer stem cells: mirage or reality Nat. Med. 15, 1010-1012 (2009).
11. Visvader, J. E. & Lindeman, G. J. Cancer stem cells: current status and evolving complexities. Cell Stem Cell 10, 717-728 (2012).
12. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
13. Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233 (2009).
14. Calin, G. A. & Croce, C. M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 6, 857-866 (2006).
15. Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593-601 (2008).
16. Bockhorn, J. et al. MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11. Nat. Commun. 4, 1393 (2013).
17. Valastyan, S. et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 137, 1032-1046 (2009).
18. Tavazoie, S. F. et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451, 147-152 (2008).
19. Shimono, Y. et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138, 592-603 (2009).
20. Rayner, K. J. et al.MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328, 1570-1573 (2010).
21. Horie, T. et al.MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice. Nat. Commun. 4, 2883. (2013).
22. Rottiers, V. et al. MicroRNAs in metabolism and metabolic diseases. Cold Spring Harb. Symp. Quant. Biol. 76, 225-233 (2011).
23. Grimson, A. et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27, 91-105 (2007).
24. Zheng, L. Baumann, U. & Reymond, J. L. An efficient one-step site-directed and site-saturation mutagenesis protocol. Nucleic Acids Res. 32, e115 (2004).
25. Dontu, G. et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 17, 1253-1270 (2003).
26. Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008).
27. Baccelli, I.&Trumpp, A. The evolving concept of cancer andmetastasis stem cells. J. Cell Biol. 198, 281-293 (2012).
28. Yang, W. H. et al. RAC1 activation mediates Twist1-induced cancer cell migration. Nat. Cell Biol. 14, 366-374 (2012).
29. Zhao, X. L. et al. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1. J. Cell. Mol. Med. 15, 691-700 (2011).
30. Sun, M. et al. RKIP and HMGA2 regulate breast tumor survival and metastasis through lysyl oxidase and syndecan-2. Oncogene 33, 3528-3537 (2013).
31. Yun, J. et al. Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer. EMBO. J. 30, 4500-4514 (2011).
32. Payne, S. L. et al. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res. 65, 11429-11436 (2005).
33. Scherr, M. et al. Lentivirus-mediated antagomir expression for specific inhibition of miRNA function. Nucleic Acids Res. 35, e149 (2007).
34. Rhodes, D. R. et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9, 166-180 (2007).
35. Zhang, Y., Yang, P. & Wang, X. F. Microenvironmental regulation of cancer metastasis by miRNAs. Trends Cell Biol. 24, 153-160 (2014).
36. Pencheva, N. & Tavazoie, S. F. Control of metastatic progression by microRNA regulatory networks. Nat. Cell Biol. 15, 546-554 (2013).
37. Zhang, Y. et al.miR-126 and miR-126 repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat. Cell Biol. 15, 284-294 (2013).
38. Wang, H. et al.miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways. J. Clin. Invest. 124, 4489-4502 (2014).
39. Fedele, M. et al. HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. Cancer Cell 9, 459-471 (2006).
40. Nishino, J., Kim, I., Chada, K. &Morrison, S. J. Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression. Cell 135, 227-239 (2008).
41. Copley, M. R. et al. The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells. Nat. Cell Biol. 15, 916-925 (2013).
42. Yu, F. et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131, 1109-1123 (2007).
43. Oikawa, T. et al. Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers. Hepatology 57, 1469-1483 (2013).
44. Zeng, S. S. et al. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma. J. Hepatol. 60, 127-134 (2014).
45. Zhang, L. et al. SALL4, a novel marker for human gastric carcinogenesis and metastasis. Oncogene 33, 5491-5500 (2014).
46. Herrera-Merchan, A. et al. miR-33-mediated downregulation of p53 controls hematopoietic stem cell self-renewal. Cell Cycle 9, 3277-3285 (2010).
47. Yang, J. et al. Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells. Proc. Natl. Acad. Sci. USA 104, 10494-10499 (2007).
48. Fang, X. et al. Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal. Oncogene 30, 4707-4720 (2011).
49. Liu, A. Y. et al. Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24. Carcinogenesis 35, 537-545 (2014).